
Huawei preps AI chip to challenge Nvidia: report
Wall Street Breakfast
00:00
Huawei's AI Ambitions and Major Biotech Deals
This chapter explores Huawei's focus on artificial intelligence with its aim to rival NVIDIA through the Ascend 910D chip, alongside Merck KGAA's significant acquisition of SpringWorks Therapeutics to strengthen its cancer treatment capabilities. Additionally, it covers CrowdStrike's launch of new AI-driven security solutions designed to improve operations in its Securities Operations Center.
Transcript
Play full episode